Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2021

Year

Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer, Laura Salazar, Keith Henry, David M. Asmuth, David A. Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi,

The Lancet HIV

Preventive MedicineWeek 96Treatment And PreventionPharmacologyClinical TrialsHiv-1 Pre-exposure ProphylaxisAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyAntiviral DrugHivMedicineTenofovir Disoproxil Fumarate